[PDF] Radiolabelled autologous cells : methods and standardization for clinical use : IAEA Human Health Series 5

Source:
International Atomic Energy Agency
Publisher:
International Atomic Energy Agency
Publication date:
01 January 2015

Abstract

This publication serves as a useful resource for nuclear medicine physicians, radiologists, radiopharmacists, pharmacologists and other researchers engaged with radiolabelling of autologous products for clinical application. It provides practical guidelines towards clinical work with radiolabelled autologous products and aims to streamline the variety of strategies that have evolved, for example, in the handling of radiolabelled red and white blood cells. The publication highlights the importance of the quality of radiolabelling services, provides advice on safety issues, and also addresses the use of other radiolabelled autologous products and their translation into the clinical environment.